Cardiac -adrenergic receptor ( -AR) signaling and left ventricular (LV) responses to -AR stimulation are impaired with aging. It is shown that exercise and -AR blockade have a favourable effect on cardiac and vascular -AR signaling in several cardiovascular diseases. In the present study, we examined the effects of these two different strategies on AR dysregulation and LV inotropic reserve in the aging heart. Forty male Wistar-Kyoto (WKY) aged rats were randomized to sedentary, exercise (12 wks treadmill training), metoprolol (250 mg/Kg/d for 4 wks), and exercise plus metoprolol treatment protocols. Ten male WKY sedentary young rats were also used as control group. Old trained, old metoprolol, and old trained plus metoprolol-treated rats showed significantly improved LV +dP/dt and -dP/dt responses to -AR stimulation (isoproterenol) compared to old untrained animals. We found a significant reduction in cardiac sarcolemmal membrane AR density and adenylyl cyclase (AC) activity in old untrained animals compared to young control ones. Exercise training as well as metoprolol, alone or combined, restored cardiac AR density and G-protein dependent AC activation in old rats. Although cardiac membrane Gprotein receptor kinase-2 (GRK2) levels were not upregulated in untrained old compared to young control rats, both exercise and metoprolol, resulted in a dramatic reduction of GRK2 protein levels, which is a further indication of AR signaling amelioration in the aged heart induced by these treatment modalities. In conclusion, we demonstrate for the first time that exercise and -AR blockade can similarly ameliorate AR signaling in the aged heart leading to improved AR responsiveness and corresponding LV inotropic reserve.
INTRODUCTION
to exercise, sedentary, metoprolol, and exercise plus metoprolol treatment protocols. In this way, we obtained 4 groups, each composed of 10 animals. In the training group, rats underwent a training program lasting 12 weeks, consisting in 5 days/week, 45 min/day, treadmill exercise with a speed running of 17 m/min. This protocol allowed to obtain an exercise relative intensity estimated at 70% to 85% of maximal oxygen uptake (38,39). In the untrained group, rats walked 10 min/d once per week to maintain treadmill familiarity. In the metoprolol group, rats were housed in sedentary conditions for a period of 10 weeks and, then, treated with the selective 1 -AR blocker, metoprolol, for a period of 4 weeks. Drug was dissolved in drinking water and administered at a daily dose of 250 mg/Kg. In the exercise plus metoprolol group, training protocol was performed as described above, and drug was administered in the last 4 weeks of the training program at a daily dose of 250 mg/Kg. Maximal exercise capacity was evaluated before starting protocols, and at 12-weeks from starting experimental procedures. Each evaluation was performed twice in each rat, in separated tests, and the average score was considered for analysis. The protocol for the maximal exercise capacity test consisted of walking at 10m/min for 5 min followed by 2m/min increases in speed every 2 min until the rat reached exhaustion. Rats were considered exhausted when they failed to stay off of a shock bar. The grade of the treadmill was set at 15°. Ten WKY sedentary young (age= 4 months; weight= 384±10) rats were also included into the study and were used as control group.
In vivo hemodynamic measurements:
At the end of sedentary, training, and drug treatment protocols, all animals underwent in vivo cardiac hemodynamic evaluation. Rats were sedated with ketamine (50 mg/kg) and xylazine (0.5 mg/kg) and venous access was obtained by way of the right external jugular vein. A 2.0 French micromanometer was placed into the LV through the left carotid artery and LV pressure was obtained using custom data acquisition software at a sampling rate of 200 Hz. Data were acquired at baseline and after infusion of isoproterenol at 0.1, 0.5, and 1.0 mg/kg/min. The LV pressure data were then analyzed on a PowerLab system (Colorado Springs, CO) with custom software to derive the maximal and minimal first derivative of the pressure rise (LV +dP/dt and LV -dP/dt, respectively), as well as heart rate, and peak systolic pressure.
Preparation of tissue fractions. At the time the rats were killed, the rat circulatory system was perfused with 20 ml of cold saline, the heart was excised, and the atria were trimmed away. The wet weight was determined. Aliquots of LV (200-300 mg) were obtained from rat hearts of aged sedentary, trained, metoprolol, and trained plus metoprolol treated groups as well from young sedentary controls. LV sections were homogenized in 15 vol of 0.25 m sucrose, 5mM EDTA, and 5 mM tris(Hydroxymethyl)-HCl (pH 7.5) at 4°C. To avoid protein degradation, protein inhibitors (2µM leupeptin, 100 µM benzamindine, and 100 µM phenylmethylsufonyl fluoride) were added to the mixture. The samples were centrifuged at 800 g for 15 min at 4°C to clear the homogenate of cellular debris and nuclei. Subsequent supernatants were filtered through cheesecloth and centrifuged at 25,000 g for 30 min at 4°C. The final supernatant was set aside for GRK2 analysis and the pelleted membranes were resuspended (~1 mg/ml) in ice-cold -AR binding buffer (75 mM tris(Hydroxymethyl)-HCl, pH 7.5, 12.5 mM MgC1 2 , 2 mM EDTA). Membranes were aliquoted and stored at 80°C until use in biochemical assays.
-AR Radioligand Binding: Membrane fractions from LV were used for -AR radioligand binding studies using the non-selective AR antagonist ligand [
125 I]-Cyanopindolol ( 125 I-CYP) as previously described (32). Maximal binding was measured using a saturating amount of 125 I-CYP on 25 µg membrane protein. Binding was allowed to occur for 1 h at 37°C. Non-specific binding was determined in the presence of 10 µM alprenolol. Reactions were conducted in 100 µl of binding buffer at 37°C for 1 h and then terminated by vacuum filtration through glass fiber filters.
All assays were performed in triplicate, and receptor density (in fmol) was normalized to milligrams of membrane protein.
Adenylyl cyclase assays. Cardiac membranes were prepared by homogenizing rat left ventricles in ice-cold lysis buffer (20 mM Tris-HCl [pH 7.4], 250 mM sucrose, 1 mM EDTA, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 0.1 mM PMSF). The samples were centrifuged at 10,000 g for 10 min at 4°C. The supernatant was centrifuged at 100,000 g for 2 h at 4°C. The pellet was resuspended in a buffer containing 20 mM Tris-HCl (pH 7.4), 1 mM EDTA up to final protein concentration of 4.5-5 mg/ml. Membranes were aliquoted and stored at 80°C. Aliquots of the cardiac membranes (20 µg total protein) were incubated for 15 min at 37°C (the incubation mixture containing: 1.6 mM [ - Table 1 shows the effects of age, training and age-training interaction on hemodynamic data and physical characteristics of young untrained and old trained and untrained rats. Heart rate and systolic blood pressure were significantly affected by aging and training. Aging and training were also significantly associated with greater body and LV weights as well as a significant age-training interaction on the reduction of LV-to-body weight ratio was found. In addition, as shown in Table 2 , metoprolol and training plus metoprolol significantly reduced heart rate and systolic blood pressure in old-treated rats. A significant reduction of LV weight and LV-tobody weight ratio was found in the metoprol treated group. These data confirm previous findings on the ability of -blockade to reduce LV hypertrophy which is a common finding associated with aging (40).
Effects of training and 1 -AR blockade on maximal exercise capacity in an old rat population.
Before starting training, metoprolol, and training plus metoprolol protocols and after randomization, exercise levels were higher in young than in older rats as expected ( Fig. 1 ).
Training but not metoprolol induced a significant increase in maximal exercise capacity in old animals ( Fig. 1) . No additional effect on maximal exercise capacity was observed in old trained animals treated with metoprolol. Interestingly, at the end of the 12 week training protocol, exercise levels were similar in old trained, and trained plus metoprolol rats and young untrained animals.
Exercise training and 1 AR blockade in older rats improve LV inotropic responses to -AR
stimulation. In old rats that were either trained or untrained, metoprolol-treated, and trained plus metoprolol treated, basal LV+dP/dt values were not statistically different from those recorded in young control rats (Table 3 ). This data indicates that aging per se is not associated with significant changes in resting LV contractility in healthy animals. Interestingly, training and -AR blockade, alone or combined, did not significantly affect basal cardiac contractility in aged rats. Basal LV-dP/dt was significantly reduced in old animals of all groups rats when compared to young control rats (Table 3) . This confirms previous data on the impairment of LV relaxation occurring with age (41).
Old untrained rats displayed a significantly impaired contractile response to -AR stimulation compared to young untrained controls, as indicated by their severely diminished isoproterenolinduced LV+dP/dt increases ( Table 3 , Fig. 2A ). Interestingly, old trained and old metoprololtreated rats showed significantly improved contractile responses to isoproterenol compared to old untrained animals. No additional effect on isoproterenol-stimulated LV+dP/dt was observed in old trained plus metoprolol-treated rats. At the highest isoproterenol dose, the increase in LV contractility was comparable between old trained and young controls, suggesting a complete restoration of cardiac inotropic reserve induced by exercise. In old metoprolol and trained plus metoprolol treated rats, LV+dP/dt responses to maximal isoproterenol stimulation were slightly lower than in young controls but dramatically higher than in old untrained animals. In old untrained rats, LV-dP/dt responses to isoproterenol were significantly reduced compared to those obtained in young sedentary controls (Table 3 , Fig. 2B ). Although row data do not clearly indicate the positive effects of different treatment protocols on LV relaxation properties (Table 3) , the analysis of LV-dP/dt delta responses to isoproterenol showed that training, metoprolol, and training plus metoprolol significantly affected LV diastolic properties in old rats (Fig. 2B) . In fact, in the treated old groups, values were higher than those observed in untrained old rats. Taken together, these results indicate that both pharmacologic and non-pharmacologic approaches ( -blocker and exercise) improve the inotropic reserve of the aged heart and ameliorate LV relaxation properties.
As expected, heart rate and systolic blood pressure responses to isoproterenol infusion were significantly blunted by metoprolol treatment in old rats and heart rate responses to AR stimulation were significantly increased in trained old rats compared to untrained old animals (Table 3 , Fig. 3A , and 3B).
Exercise training and AR blockade rescue aging-induced reduction of cardiac AR density and adenylyl cyclase activity. As shown in Table 4 , aging is associated with cardiac -AR downregulation indicated by the significant reduction in sarcolemmal membrane -AR density in aged rat hearts compared to young control ones. Importantly, exercise training as well as metoprolol, and training plus metoprolol restored cardiac -AR density to the levels of young control rats. In association with a loss in -AR density in aged rat hearts, myocardial samples from untrained old rats displayed a severe reduction in basal cAMP levels compared to young control rat hearts and an almost complete inability to increase cAMP production in response to isoproterenol + GTP, and - (Table 4 , Fig. 4 ). In order to evaluate whether the decrease with age in the activation of AC was also correlated with a reduced number of AC catalytic units, we further assessed stimulation of AC by forskolin. Interestingly, the sensitivity for forskolin activation was also reduced in old untrained rats. As with -AR density, both exercise training and metoprolol, alone or combined, induced, in old rat hearts, an almost complete restoration of cAMP levels under basal conditions and in response to isoproterenol+GTP, and Gpp(NH)p (Table 4 , Fig. 4 ). In contrast, AC activation by forskolin was not favourably affected by different treatment strategies. Taken togheter, these data indicate that training and metoprolol are able to correct the age-related impairment of G-protein dependent mechanisms of AC activation but not those limited by the number of AC catalytic units.
Exercise training and -AR blockade down-regulate GRK2 in old rat hearts. As shown in Fig.   5 , although cardiac membrane GRK2 levels are not altered in untrained old rats compared to young control rats, both exercise training and metoprolol, alone or combined, resulted in a dramatic reduction of cardiac GRK2 protein levels in old rats, which is a further indication of AR signaling amelioration in the aged heart induced by these treatment modalities.
DISCUSSION
In this study, we demonstrate for the first time that two different treatment strategies, such as exercise training and selective 1 -AR blockade by metoprolol, alone or combined, favorably alter -AR signaling in the aged heart. This improvement occurred via increased cardiac -AR density and reversal of receptor desensitization and uncoupling from AC stimulation. The latter was due to a reduction of cardiac GRK2 levels due to both exercise and metoprolol. These molecular changes in the myocardial -AR system led to improved -AR responsiveness and corresponding inotropic reserve in the aged rat heart. The role of -AR down-regulation in the determination of aging-related cardiac -AR dysfunction is somewhat controversial (33,42), however, receptor desensitization/uncoupling are well characterized phenomena in aged myocardium (25,32,33,42). It has been shown that increased levels of cardiac GRK2 play a key role in dysregulation of the -AR pathway in human and animal models of heart failure (9-12). This kinase phosphorylates GPCRs and leads to functional uncoupling of the receptors from downstream effector systems (9). Previous observations from our group showed that aging was associated with a significant reduction of vascular -AR responses due to receptor downregulation and desensitization (32). Furtheromore, endothelial GRK2 upregulation was shown to be associated with -AR dysfunction in aged rat carotids (32).
Importantly, like we have now shown in myocardium in this study, we previously found that exercise training improved vascular -AR reactivity by reducing GRK2 activity (32).
At the cardiac level, the molecular mechanisms responsible for age-related -AR dysfunction have not been clearly elucidated. In an earlier study, it was reported that the positive inotropic effects of both 1 and 2 -AR stimulation were markedly decreased with aging in rat ventricular myocytes and this was accompanied by decreases in both -AR subtype densities and a reduction in membrane AC activity (42). In this study, neither GRK2, GRK5 nor G i proteins seemed to contribute to the age-associated cardiac -AR desensitization (42). Accordingly, in the present study, cardiac levels of GRK2 were not different among old and young rats, however, we hypothesize that, despite comparable protein concentrations in both age groups, the net effect of GRK2 on -AR desensitization/uncoupling may be higher in older myocytes, which have a marked reduction of membrane AR density. More importantly, both treatment strategies used in this study, training and -blockade, alone or combined, significantly decreased cardiac GRK2 levels in aged rat hearts and this was associated with a significant increase of basal and -AR-stimulated, Gprotein dependent AC activation. The observation that forskolin-stimulated AC activity was still depressed after treatment protocols indicate that training and -AR blockade, alone or combined,
were not able to favorably affect the age-dependent defect of AC catalytic units (42,43). This finding seems to further support our hypothesis of a key role of GRK2 in determining -AR dysfunction in the aged heart.
Of note, other studies support the hypothesis that the actions of GRKs are extremely important in modulating myocardial adrenergic signaling and cardiac function in physiologic conditions as well as in disease states (2, 9) . In this regard, it is important to note that it has been shown that -AR blockade by selective and non selective agents, such as atenolol and carvedilol, is able to improve cardiac AR signaling by significantly reducing cardiac GRK2 levels in healthy mice (37,44). In addition, inhibition of GRK2 activity in myocytes due to expression of the ARKct peptide enhances contractility in healthy mice (15) and improves -AR inotropic reserve in failing myocardium (16) (17) (18) (19) . These studies confirm that GRK2 can modulate -AR signaling and controls cardiac function even in physiologic conditions (9). This seems to be the case also of aged myocardium as we have now demonstrated via the enhanced cardiac contractile responses to -AR stimulation in trained old rats as well as in metoprolol treated animals.
It is noteworthy that, in this study, no additional effects on -AR signaling and cardiac inotropism were observed in old animals when training and metoprolol treatment were combined. This finding could be probably ascribed to the fact that training and -AR blockade were already able to induce a complete restoration of -AR pathway and cardiac -AR responsiveness when adopted
separately.
An important observation of this study includes the ability of selective 1 AR blockade to reverse receptor desensitization by up-regulating cardiac membrane -AR levels and decreasing GRK2
levels. This represents a "paradox" of -blocker therapy and may explain, at least in part, how long-term application of negative inotropic compounds can increase cardiac index, exercise capacity, and survival. To the best of our knowledge, this study demonstrates for the first time that -blockade has resensitization activity on -ARs in the aging heart.
Despite similar biochemical responses, training and -AR blockade had different effects on maximal exercise capacity that significantly increased in old trained animals while it remained unchanged in old-metoprolol treated rats. These findings are in accordance with those reported in previous human studies indicating that long-term treatment with -AR antagonists does not increase exercise capacity in patients with heart failure, despite improvements in hemodynamics at rest and left ventricular ejection fraction (45, 46). A plausible explanation for this phenomenon is that in heart failure, as well as with aging, the causes of exercise intolerance are multifactorial and cannot be exclusively reconducted to the decrease of cardiac performance. Abnormalities of ventilatory function, endothelial dysfunction with altered vascular adaptations, and abnormalities of skeletal muscle including atrophy and abnormal muscle metabolic responses are all factors which may account for the reduced exercise capacity in heart failure. Exercise has been shown more effective than -blockers in favourably affecting these extracardiac components in heart failure (47, 48).
The results of this study could have important clinical implications due to the high prevalence in the elderly of cardiovascular diseases, such as hypertension and heart failure, which are known to be associated with severe -AR dysfunction. In these patients, the negative effect of the disease on cardiac and vascular -AR pathway may be exacerbated by the physiological receptor deterioration occurring with age and explain, at least in part, the worse prognosis of cardiovascular diseases in the geriatric population. The results of this and other studies in this field may be reason to promote the implementation of -blocker therapy in such high risk populations thanks to the positive action of this class of drugs in restoring -AR signaling and function.
In conclusion, our data indicate that age-related cardiac -AR dysfunction is a reversible phenomenon and that both pharmacologic and non-pharmacologic interventions, such as -blockers and exercise respectively, may induce a significant improvement of signaling at receptor and postreceptor levels, including at the critical level of GRK2 activity. This adds novel information on the molecular mechanisms by which these two different strategies exert their favorable action in the treatment of cardiovascular diseases in the elderly population, as well. between old untrained and trained rats. ^ p< .01 for age-training interaction. 
